Orthopedic fractures create massive public health problems around the world. They lead to serious illness, suffering, and disabilities that last for years. In 2019, the world saw about 178 million new fractures—a 33.4% jump since 1990—driven mostly by aging populations and more road and workplace injuries. Experts predict 13.5 million fragility fractures each year by 2025. Good pain control for these patients needs a mix of immobilization, meds, and other therapies. This study compares non-opioid painkillers like NSAIDs looking at how effectively they relieve pain and how safe they are for patients with multiple fractures. We conducted a real-world observational study, following 100 patients over six months and noted their age, gender, what bones broke, how it happened, and how NSAIDs vs. opioids handled their pain—plus any side effects. Musculoskeletal injuries hit males harder, especially in the 31–40 age group, with road traffic accidents as the top cause. Tramadol plus paracetamol has shown a knocked pain down more than diclofenac plus paracetamol, along with some treatable adverse events. Both combinations help to reduce pain, but they act different. One combination may be stronger than the other, cause more side effects, or be more difficult for patients to take regularly. When a patient has mild to moderate pain, diclofenac combined with paracetamol is a practical and suitable option that works well, but when the pain is severe, tramadol with paracetamol pulls ahead — it offers stronger relief, fewer adverse events, reduces overall tramadol doses.